Recent studies using DNA microarray techniques suggested that approximately 300 genes were altered by TCDD-dependent AhR activation in the human hepatoma HepG2 cells (Puga et al. 2000b; Frueh et al. 2001). Here, AHR is linked to hepatocellular carcinoma.